Why the study?
Does myocardial viability assessed by low dose dobutamine echocardiography predict improvement in ejection fraction at 3 months in patients after acute myocardial infarction?
Population
107 patients assessed at mean 3 (SD 1) days after acute myocardial infarction
Comparison
Low dose dobutamine echocardiography to assess… vs Patients without myocardial viability
Design
Cohort
Follow-up
3 months
Authors
Loading...
Myocardial viability assessed by low-dose dobutamine echocardiography early after acute myocardial infarction is a strong independent predictor of subsequent improvement in left ventricular ejection fraction.
Does myocardial viability assessed by low dose dobutamine echocardiography predict improvement in ejection fraction at 3 months in patients after acute myocardial infarction?
Myocardial viability assessed by low-dose dobutamine echocardiography early after acute myocardial infarction is a strong independent predictor of subsequent improvement in left ventricular ejection fraction.
Francisca Nijland (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: